Cargando…
Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system
BACKGROUND: Neoadjuvant chemotherapy (NAC) is widely used in the treatment of primary breast cancer. Different staging systems have been developed to evaluate the residual tumor after NAC and classify patients into different prognostic groups. Ki67, a proliferation marker, has been shown to be usefu...
Autores principales: | Sullu, Yurdanur, Tomak, Leman, Demirag, Guzin, Kuru, Bekir, Ozen, Necati, Karagoz, Filiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597910/ https://www.ncbi.nlm.nih.gov/pubmed/37875716 http://dx.doi.org/10.1007/s12672-023-00809-w |
Ejemplares similares
-
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore
por: Laas, Enora, et al.
Publicado: (2021) -
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study
por: Xu, Ling, et al.
Publicado: (2021) -
External verification and improvement of the Neo-Bioscore staging system in a Chinese cohort
por: Geng, Rui, et al.
Publicado: (2022) -
Validation of CPS+EG, Neo‐Bioscore, and modified Neo‐Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China
por: Xu, Ling, et al.
Publicado: (2018) -
Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers
por: Demirag, Guzin G, et al.
Publicado: (2011)